BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Key Strategies for Positioning Cell Therapy CDMO Services – Size & Specificity
Strategies for Positioning Cell Therapy CDMO Services

Key Strategies for Positioning Cell Therapy CDMO Services – Size & Specificity

July 24, 2017 By Cade Hildreth (CEO) Leave a Comment

A contract development and manufacturing organization (CDMO), is a company that serves cell therapy companies on a contract basis. Common cell therapy CDMO services include cell therapy product development, manufacturing, clinical trial support, and commercial supply.

Discover class-defining bioproduction tools.

CDMOs allows cell therapy companies to outsource aspects of their business, which can support:

  1. Scalability
  2. Speed to market
  3. Adding technical expertise without overhead costs
  4. Cost efficiencies

Cell Therapy CDMO Services

Over the past several years, the biopharmaceutical industry has witnessed an increasing number of contract suppliers taking on the CDMO acronym to identify their ability to assist at the development stage of drug manufacturing.

The CDMO acronym indicates that a company is interested in differentiating their abilities from contract manufacturing organizations (CMOs) focused solely on large-scale manufacturing projects. This has been true within the cell therapy CDMO market, as well as within the broader biopharmaceutical CDMO market.

Rooster DevServices

Key Strategies for Positioning Cell Therapy CDMOs

The best-positioned cell therapy CDMOs tend to take one of two approaches. They either position themselves to outspend and out-build the competition (e.g. WuXi’s massive global expansion), or they compete at the opposite end of the spectrum by specializing in specific manufacturing technologies and cell types.

For example, a cell therapy CDMO may develop extensive expertise in T-cells, commonly used within immunotherapies, or mesenchymal stem cells, the most common stem cell type being explored in clinical trials worldwide. This positions cell therapy CDMOs to attract future clients based on their expertise with specific cell types.

bitbio

Alternatively, a cell therapy CDMO may specialize in specific manufacturing technologies, such as closed-system bioreactors, which allows for rapid for scale-up of cell populations. Today, many cell therapies are manufactured in cleanrooms, but closed-system bioreactors will be the future of cell therapy manufacturing. Closed systems reduce risks of cross-contamination and allow simultaneous processing of multiple product batches, providing huge cost savings through facility efficiency and streamlined labor.

With lower-cost international manufacturers trying to capture a growing percentage of the market, specialization provides an effective hedge against loss of market share for smaller players within the cell therapy CDMO market.

Pluristyx

To learn more, view the “Market Size Determination for the Cell Therapy CDMO Market.”

Cell Therapy CDMO Market Size

5/5 - (2 votes)

Filed Under: Stem Cells Tagged With: CDMO, cell therapy, manufacturing

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

clean meat market

Clean Meat Market: Stem Cell Derived “Clean Meat” Attracts Billionaires

what are exosomes | definition

What are Exosomes, Exactly?

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.